CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy Director bought 104,166 shares at $9.60 ($999,994)
- 144 Insider Sale of Securities
- 4 Open-market sale President and CEO sold 5,062 shares at $8.08 ($40,883)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes Director gave up 60 shares (to pay taxes)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Grant or award Director acquired 24,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Shareholder vote results
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
Page 1 of 57 · 1,133 filings